Studying at the University of Verona

Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.

Study Plan

This information is intended exclusively for students already enrolled in this course.
If you are a new student interested in enrolling, you can find information about the course of study on the course page:

Laurea magistrale in Molecular and Medical Biotechnology - Enrollment from 2025/2026

The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.

1° Year

ModulesCreditsTAFSSD
One course to be chosen among the following:
One course to be chosen among the following

2° Year  activated in the A.Y. 2016/2017

ModulesCreditsTAFSSD
Stage
2
F
-
Prova finale
40
E
-
ModulesCreditsTAFSSD
One course to be chosen among the following:
One course to be chosen among the following
activated in the A.Y. 2016/2017
ModulesCreditsTAFSSD
Stage
2
F
-
Prova finale
40
E
-

Legend | Type of training activity (TTA)

TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.




S Placements in companies, public or private institutions and professional associations

Teaching code

4S003688

Coordinator

Daniela Cecconi

Credits

6

Language

English en

Scientific Disciplinary Sector (SSD)

CHIM/01 - ANALYTICAL CHEMISTRY

Period

I sem. dal Oct 3, 2016 al Jan 31, 2017.

Learning outcomes

The aim of clinical proteomics is actually to find molecular signatures, to describe affected pathways and possibly identify candidate biomarkers that can help in the diagnosis, prognosis and prediction of therapeutic outcomes and elucidate pathogenic mechanisms.

Clinical proteomics course aims to give an overview of proteomics methodologies and their application to current areas of clinical investigation.

Program

CLINICAL PROTEOMICS
Introduction to clinical proteomics.
Strategies for protein sample preparation.
Gel-based and gel-free clinical proteomics analyses.
Protein Identification by Tandem Mass Spectrometry.
Label-Based MS clinical proteomic approaches.
Advances in clinical proteomics research for biomarkers discovery.
Clinical Proteomics for elucidating the mechanism of action of anticancer drugs.
Clinical Proteomics to study Pancreatic Cancer Stem Cells
Hepcidin assay and clinical application
Recent Advances in Cardiovascular disease

Examination Methods

The final exam includes the presentation of a scientific paper and a written exam that will cover all the topics of the program.

Students with disabilities or specific learning disorders (SLD), who intend to request the adaptation of the exam, must follow the instructions given HERE